nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ITGAL—Behcet's disease	0.923	1	CbGaD
Lovastatin—Simvastatin—ITGB2—Behcet's disease	0.00812	1	CrCbGaD
Lovastatin—ITGAL—Integrin family cell surface interactions—ITGB2—Behcet's disease	0.00488	0.134	CbGpPWpGaD
Lovastatin—ITGAL—Beta2 integrin cell surface interactions—ITGB2—Behcet's disease	0.00447	0.123	CbGpPWpGaD
Lovastatin—ITGAL—endothelium—Behcet's disease	0.00419	0.128	CbGeAlD
Lovastatin—ITGAL—blood vessel—Behcet's disease	0.00386	0.118	CbGeAlD
Lovastatin—ITGAL—Integrin cell surface interactions—ITGB2—Behcet's disease	0.00231	0.0637	CbGpPWpGaD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—ITGB2—Behcet's disease	0.00221	0.0607	CbGpPWpGaD
Lovastatin—ITGAL—Cell surface interactions at the vascular wall—ITGB2—Behcet's disease	0.00167	0.046	CbGpPWpGaD
Lovastatin—ITGAL—Beta2 integrin cell surface interactions—ICAM1—Behcet's disease	0.00167	0.0459	CbGpPWpGaD
Lovastatin—ITGAL—Integrin-mediated Cell Adhesion—ITGB2—Behcet's disease	0.00166	0.0457	CbGpPWpGaD
Lovastatin—ITGAL—mammalian vulva—Behcet's disease	0.00163	0.0497	CbGeAlD
Lovastatin—PON3—mammalian vulva—Behcet's disease	0.0016	0.0488	CbGeAlD
Lovastatin—ITGAL—medulla oblongata—Behcet's disease	0.00147	0.0449	CbGeAlD
Lovastatin—ITGAL—midbrain—Behcet's disease	0.00134	0.041	CbGeAlD
Lovastatin—ITGAL—spinal cord—Behcet's disease	0.00131	0.04	CbGeAlD
Lovastatin—HDAC2—mouth—Behcet's disease	0.00129	0.0394	CbGeAlD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—HLA-B—Behcet's disease	0.00101	0.0279	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—ITGB2—Behcet's disease	0.000993	0.0273	CbGpPWpGaD
Lovastatin—ITGAL—Integrin cell surface interactions—ICAM1—Behcet's disease	0.000863	0.0238	CbGpPWpGaD
Lovastatin—HMGCR—Statin Pathway—APOB—Behcet's disease	0.000852	0.0235	CbGpPWpGaD
Lovastatin—ITGAL—brain—Behcet's disease	0.000845	0.0258	CbGeAlD
Lovastatin—HDAC2—brainstem—Behcet's disease	0.000843	0.0257	CbGeAlD
Lovastatin—ITGAL—Cell surface interactions at the vascular wall—APOB—Behcet's disease	0.00083	0.0228	CbGpPWpGaD
Lovastatin—PON3—brain—Behcet's disease	0.000829	0.0253	CbGeAlD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—ICAM1—Behcet's disease	0.000824	0.0227	CbGpPWpGaD
Lovastatin—HDAC2—eye—Behcet's disease	0.000821	0.0251	CbGeAlD
Lovastatin—HDAC2—retina—Behcet's disease	0.000814	0.0248	CbGeAlD
Lovastatin—ITGAL—Extracellular matrix organization—ITGB2—Behcet's disease	0.000763	0.021	CbGpPWpGaD
Lovastatin—HDAC2—skin of body—Behcet's disease	0.000714	0.0218	CbGeAlD
Lovastatin—HMGCR—Statin Pathway—APOA1—Behcet's disease	0.000674	0.0186	CbGpPWpGaD
Lovastatin—HMGCR—skin of body—Behcet's disease	0.000644	0.0197	CbGeAlD
Lovastatin—HDAC2—medulla oblongata—Behcet's disease	0.000588	0.0179	CbGeAlD
Lovastatin—HMGCR—mammalian vulva—Behcet's disease	0.000588	0.0179	CbGeAlD
Lovastatin—HMGCR—cardiac atrium—Behcet's disease	0.000563	0.0172	CbGeAlD
Lovastatin—HDAC2—midbrain—Behcet's disease	0.000537	0.0164	CbGeAlD
Lovastatin—HMGCR—medulla oblongata—Behcet's disease	0.000531	0.0162	CbGeAlD
Lovastatin—ITGAL—Adaptive Immune System—ERAP1—Behcet's disease	0.00053	0.0146	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—MICA—Behcet's disease	0.000526	0.0145	CbGpPWpGaD
Lovastatin—HMGCR—midbrain—Behcet's disease	0.000485	0.0148	CbGeAlD
Lovastatin—HMGCR—spinal cord—Behcet's disease	0.000473	0.0144	CbGeAlD
Lovastatin—ITGAL—Hemostasis—ITGB2—Behcet's disease	0.000454	0.0125	CbGpPWpGaD
Lovastatin—HDAC2—nervous system—Behcet's disease	0.000442	0.0135	CbGeAlD
Lovastatin—HDAC2—central nervous system—Behcet's disease	0.000425	0.013	CbGeAlD
Lovastatin—SLCO1A2—medulla oblongata—Behcet's disease	0.000414	0.0126	CbGeAlD
Lovastatin—HMGCR—nervous system—Behcet's disease	0.000399	0.0122	CbGeAlD
Lovastatin—ITGAL—Adaptive Immune System—ITGB2—Behcet's disease	0.000392	0.0108	CbGpPWpGaD
Lovastatin—HMGCR—central nervous system—Behcet's disease	0.000384	0.0117	CbGeAlD
Lovastatin—SLCO1A2—midbrain—Behcet's disease	0.000378	0.0115	CbGeAlD
Lovastatin—SLCO1A2—spinal cord—Behcet's disease	0.000369	0.0113	CbGeAlD
Lovastatin—ABCB1—blood vessel—Behcet's disease	0.000364	0.0111	CbGeAlD
Lovastatin—ITGAL—Immune System—MEFV—Behcet's disease	0.000361	0.00993	CbGpPWpGaD
Lovastatin—HDAC2—brain—Behcet's disease	0.000338	0.0103	CbGeAlD
Lovastatin—ITGAL—Immune System—ERAP1—Behcet's disease	0.000322	0.00885	CbGpPWpGaD
Lovastatin—ABCC2—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.000312	0.00858	CbGpPWpGaD
Lovastatin—SLCO1A2—nervous system—Behcet's disease	0.000311	0.00949	CbGeAlD
Lovastatin—HMGCR—brain—Behcet's disease	0.000305	0.0093	CbGeAlD
Lovastatin—SLCO1A2—central nervous system—Behcet's disease	0.000299	0.00913	CbGeAlD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—IL10—Behcet's disease	0.000291	0.00802	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—ICAM1—Behcet's disease	0.000285	0.00784	CbGpPWpGaD
Lovastatin—CYP2D6—brainstem—Behcet's disease	0.000276	0.00843	CbGeAlD
Lovastatin—ITGAL—Adaptive Immune System—CTLA4—Behcet's disease	0.000243	0.0067	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—SERPINE1—Behcet's disease	0.000238	0.00655	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—ITGB2—Behcet's disease	0.000238	0.00654	CbGpPWpGaD
Lovastatin—SLCO1A2—brain—Behcet's disease	0.000238	0.00725	CbGeAlD
Lovastatin—HMGCR—PPARA activates gene expression—APOA1—Behcet's disease	0.000232	0.00639	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.00023	0.00633	CbGpPWpGaD
Lovastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—Behcet's disease	0.000227	0.00625	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—APOB—Behcet's disease	0.000225	0.00619	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—ICAM1—Behcet's disease	0.000223	0.00614	CbGpPWpGaD
Lovastatin—ABCB1—retina—Behcet's disease	0.000192	0.00585	CbGeAlD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—SERPINE1—Behcet's disease	0.000188	0.00518	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—HLA-B—Behcet's disease	0.00018	0.00495	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—APOA1—Behcet's disease	0.000178	0.0049	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000178	0.00489	CbGpPWpGaD
Lovastatin—CYP2C8—brain—Behcet's disease	0.000166	0.00507	CbGeAlD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Behcet's disease	0.000161	0.00443	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—CXCL8—Behcet's disease	0.000158	0.00434	CbGpPWpGaD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—Behcet's disease	0.000157	0.00431	CbGpPWpGaD
Lovastatin—ABCB1—mammalian vulva—Behcet's disease	0.000154	0.00468	CbGeAlD
Lovastatin—ITGAL—Immune System—CTLA4—Behcet's disease	0.000148	0.00406	CbGpPWpGaD
Lovastatin—CYP3A4—nervous system—Behcet's disease	0.000147	0.00449	CbGeAlD
Lovastatin—ABCB1—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.000147	0.00403	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—ICAM1—Behcet's disease	0.000146	0.00403	CbGpPWpGaD
Lovastatin—CYP2D6—nervous system—Behcet's disease	0.000145	0.00442	CbGeAlD
Lovastatin—CYP3A4—central nervous system—Behcet's disease	0.000142	0.00432	CbGeAlD
Lovastatin—ITGAL—Hemostasis—SERPINE1—Behcet's disease	0.000141	0.00389	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ITGB2—Behcet's disease	0.000139	0.00384	CbGpPWpGaD
Lovastatin—CYP2D6—central nervous system—Behcet's disease	0.000139	0.00425	CbGeAlD
Lovastatin—ABCB1—medulla oblongata—Behcet's disease	0.000139	0.00423	CbGeAlD
Lovastatin—ITGAL—Hemostasis—NOS3—Behcet's disease	0.000135	0.00371	CbGpPWpGaD
Lovastatin—ABCB1—midbrain—Behcet's disease	0.000127	0.00387	CbGeAlD
Lovastatin—HDAC2—Hemostasis—ITGAL—Behcet's disease	0.000126	0.00346	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—TNF—Behcet's disease	0.000125	0.00343	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CTLA4—Behcet's disease	0.000124	0.0034	CbGpPWpGaD
Lovastatin—ABCB1—spinal cord—Behcet's disease	0.000124	0.00377	CbGeAlD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000123	0.00338	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—SERPINE1—Behcet's disease	0.000121	0.00334	CbGpPWpGaD
Lovastatin—CYP2D6—brain—Behcet's disease	0.000111	0.00338	CbGeAlD
Lovastatin—ITGAL—Immune System—HLA-B—Behcet's disease	0.000109	0.003	CbGpPWpGaD
Lovastatin—ABCB1—nervous system—Behcet's disease	0.000104	0.00318	CbGeAlD
Lovastatin—ABCB1—central nervous system—Behcet's disease	0.0001	0.00306	CbGeAlD
Lovastatin—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	9.66e-05	0.00266	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL10—Behcet's disease	9.61e-05	0.00264	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—HLA-B—Behcet's disease	9.14e-05	0.00252	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—SERPINE1—Behcet's disease	9.1e-05	0.0025	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—ICAM1—Behcet's disease	8.87e-05	0.00244	CbGpPWpGaD
Lovastatin—ABCB1—brain—Behcet's disease	7.96e-05	0.00243	CbGeAlD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	7.88e-05	0.00217	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	7.16e-05	0.00197	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—APOB—Behcet's disease	6.92e-05	0.0019	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	6.23e-05	0.00172	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—APOA1—Behcet's disease	5.47e-05	0.00151	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	5.25e-05	0.00145	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCR1—Behcet's disease	4.97e-05	0.00137	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	4.76e-05	0.00131	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—APOB—Behcet's disease	4.52e-05	0.00124	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—SERPINE1—Behcet's disease	4.35e-05	0.0012	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—NOS3—Behcet's disease	4.15e-05	0.00114	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—APOB—Behcet's disease	4.12e-05	0.00113	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	4.07e-05	0.00112	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—APOB—Behcet's disease	3.87e-05	0.00106	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	3.76e-05	0.00104	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TNF—Behcet's disease	3.66e-05	0.00101	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CAT—Behcet's disease	3.61e-05	0.000995	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—APOA1—Behcet's disease	3.58e-05	0.000984	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—APOB—Behcet's disease	3.51e-05	0.000965	CbGpPWpGaD
Lovastatin—HDAC2—Disease—APOB—Behcet's disease	3.35e-05	0.000922	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—APOA1—Behcet's disease	3.26e-05	0.000896	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	3.22e-05	0.000885	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—APOA1—Behcet's disease	3.06e-05	0.000842	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CAT—Behcet's disease	2.95e-05	0.000811	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—APOB—Behcet's disease	2.86e-05	0.000787	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—APOA1—Behcet's disease	2.78e-05	0.000764	CbGpPWpGaD
Lovastatin—HDAC2—Disease—APOA1—Behcet's disease	2.65e-05	0.000729	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CAT—Behcet's disease	2.51e-05	0.000689	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—APOB—Behcet's disease	2.43e-05	0.000669	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APOB—Behcet's disease	2.35e-05	0.000645	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	2.34e-05	0.000643	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—SERPINE1—Behcet's disease	2.27e-05	0.000623	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—APOA1—Behcet's disease	2.26e-05	0.000623	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CAT—Behcet's disease	2.18e-05	0.0006	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—APOB—Behcet's disease	2.12e-05	0.000583	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—NOS3—Behcet's disease	2.1e-05	0.000579	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SERPINE1—Behcet's disease	2.1e-05	0.000579	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	2.09e-05	0.000574	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CAT—Behcet's disease	2.04e-05	0.00056	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOS3—Behcet's disease	2.01e-05	0.000553	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—APOB—Behcet's disease	1.98e-05	0.000544	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	1.94e-05	0.000533	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—APOA1—Behcet's disease	1.92e-05	0.000529	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	1.9e-05	0.000523	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CAT—Behcet's disease	1.87e-05	0.000513	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APOA1—Behcet's disease	1.86e-05	0.000511	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	1.85e-05	0.000509	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—APOB—Behcet's disease	1.81e-05	0.000498	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	1.81e-05	0.000497	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—NOS3—Behcet's disease	1.72e-05	0.000472	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CAT—Behcet's disease	1.71e-05	0.000471	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—APOA1—Behcet's disease	1.68e-05	0.000461	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APOB—Behcet's disease	1.66e-05	0.000457	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	1.65e-05	0.000454	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—APOA1—Behcet's disease	1.56e-05	0.00043	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	1.53e-05	0.000421	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	1.5e-05	0.000414	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SERPINE1—Behcet's disease	1.47e-05	0.000405	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—NOS3—Behcet's disease	1.46e-05	0.000401	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—APOA1—Behcet's disease	1.43e-05	0.000394	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOS3—Behcet's disease	1.41e-05	0.000387	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APOA1—Behcet's disease	1.32e-05	0.000362	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—NOS3—Behcet's disease	1.27e-05	0.000349	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL8—Behcet's disease	1.25e-05	0.000343	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CAT—Behcet's disease	1.24e-05	0.000341	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOB—Behcet's disease	1.2e-05	0.000331	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—NOS3—Behcet's disease	1.19e-05	0.000326	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NOS3—Behcet's disease	1.09e-05	0.000299	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CAT—Behcet's disease	1.07e-05	0.000295	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOB—Behcet's disease	1.04e-05	0.000286	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NOS3—Behcet's disease	9.97e-06	0.000274	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CAT—Behcet's disease	9.57e-06	0.000263	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOA1—Behcet's disease	9.51e-06	0.000262	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CAT—Behcet's disease	9.34e-06	0.000257	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOB—Behcet's disease	9.29e-06	0.000256	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOB—Behcet's disease	9.07e-06	0.000249	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CAT—Behcet's disease	8.8e-06	0.000242	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CAT—Behcet's disease	8.73e-06	0.00024	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOB—Behcet's disease	8.54e-06	0.000235	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOB—Behcet's disease	8.47e-06	0.000233	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOA1—Behcet's disease	8.23e-06	0.000227	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOA1—Behcet's disease	7.35e-06	0.000202	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NOS3—Behcet's disease	7.2e-06	0.000198	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOA1—Behcet's disease	7.17e-06	0.000197	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOA1—Behcet's disease	6.76e-06	0.000186	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOA1—Behcet's disease	6.7e-06	0.000184	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NOS3—Behcet's disease	6.24e-06	0.000172	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CAT—Behcet's disease	5.75e-06	0.000158	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOB—Behcet's disease	5.59e-06	0.000154	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NOS3—Behcet's disease	5.57e-06	0.000153	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NOS3—Behcet's disease	5.44e-06	0.00015	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NOS3—Behcet's disease	5.12e-06	0.000141	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NOS3—Behcet's disease	5.08e-06	0.00014	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOA1—Behcet's disease	4.42e-06	0.000122	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NOS3—Behcet's disease	3.35e-06	9.22e-05	CbGpPWpGaD
